Skip to main content
. 2022 May;345:190–199. doi: 10.1016/j.jconrel.2022.03.008

Fig. 5.

Fig. 5

(A) Schematic of nanoparticle transport accounting for particle binding to cancer cells. Effect of drug release constant, krel, and binding rate constant, kon, on tumor volume for (B) 20 nm particles specified to CRLX101, (C) 100 nm particles specified to Doxil and (D) 100 nm particles with increased potency of the carrying chemotherapy.